Showing results (5651-5660 of 37,639) with videos related to
Sort By:
Pageof 3,764
Cancers|February 11, 2023
The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® TestingBradley M Turner, Brian S Finkelman, David G Hicks, et al.Cancers|February 11, 2023
Chemotherapeutics Used for High-Risk Neuroblastoma Therapy Improve the Efficacy of Anti-GD2 Antibody Dinutuximab Beta in Preclinical Spheroid ModelsSascha Troschke-Meurer, Maxi Zumpe, Lena Meißner, et al.Cancers|February 11, 2023
SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue SarcomaErlinda Maria Gordon, Sant P Chawla, Walter Andree Tellez, et al.Cancers|February 11, 2023
PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application-A Literature ReviewSilvia Taralli, Margherita Lorusso, Elisabetta Perrone, et al.Cancers|February 11, 2023
Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center ExperienceMohamed E Abdelsalam, Ahmed Awad, Ali Baiomy, et al.Cancers|February 11, 2023
Immune Checkpoint Receptor/Ligand Expression and Chemotherapy in Colorectal CancerRoberto Benelli, Maria Raffaella Zocchi, Alessandro PoggiCancers|February 11, 2023
Dynamic Changes in Microvascular Density Can Predict Viable and Non-Viable Areas in High-Risk NeuroblastomaLaura Privitera, Layla Musleh, Irene Paraboschi, et al.Cancers|February 11, 2023
Vemurafenib and Dabrafenib Downregulates RIPK4 LevelEwelina Madej, Anna A Brożyna, Agnieszka Adamczyk, et al.Cancers|February 11, 2023
Impact of Aggregation Methods for Texture Features on Their Robustness Performance: Application to Nasopharyngeal 18F-FDG PET/CTLihong Peng, Hui Xu, Wenbing Lv, et al.Cancers|November 13, 2025
The Impact on the Therapeutic Decision of Massive Gene Sequencing (NGS) in Plasma from Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)Paula Llor-Rodriguez, Ana Blasco-Cordellat, Sonia Macia-Escalante, et al.Pageof 3,764